PHINIA (PHIN) director awarded 41 deferred stock units and now holds 8,551 DRSUs
Rhea-AI Filing Summary
Weerasinghe Rohan reported acquisition or exercise transactions in this Form 4 filing.
PHINIA Inc. director Rohan Weerasinghe received a grant of 41 deferred restricted stock units (DRSUs) on March 20, 2026. Each DRSU is economically equivalent to one share of common stock and will vest on the one-year anniversary of the grant date under the company’s Director Deferred Compensation Program and 2023 Stock Incentive Plan.
After this grant, Weerasinghe holds 8,551 DRSUs and directly holds 22,686 shares of PHINIA common stock, with an additional 12 shares held indirectly through a managed account. The grant is a compensation-related award, not an open-market purchase.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Restricted Stock Units | 41 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Each deferred restricted stock unit ("DRSU") is the economic equivalent of one share of PHINIA Inc. common stock and will vest on the one-year anniversary of the grant date. These DRSUs will settle into an equal number of shares of the issuer's Common Stock, including any additional DRSUs acquired as a result of dividend equivalents that have vested, upon the reporting person's termination of board service pursuant to the issuer's Director Deferred Compensation Program and 2023 Stock Incentive Plan. Represents shares of DRSUs acquired following the automatic reinvestment of dividends on outstanding DRSUs held on the dividend record date, as required by the terms of such award.
FAQ
What did PHINIA (PHIN) director Rohan Weerasinghe receive in this Form 4 filing?
How do PHINIA (PHIN) deferred restricted stock units work for this director grant?
What are Rohan Weerasinghe’s total PHINIA (PHIN) deferred restricted stock unit holdings?
Is the PHINIA (PHIN) Form 4 transaction an open-market buy or sell?